Dose Dense, High Intensity Therapy in Newly Diagnosed Elderly Patients with Acute Myeloid Leukemia Using Gemtuzumab Ozogamicin (Mylotarg™) and High Dose Cytarabine (HiDAC).
Year: 2004
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Arati V. Rao, David A. Rizzieri, Joseph O. Moore, Carlos DeCastro, Amy P. Abernethy, McLean Jordan, Patty Davis, Emily Edmonds, Jon P. Gockerman
Institutions: Duke Medical Center, Duke University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2566239268